What Baxter International Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 3 | 40 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 40 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Hider Andrew P. | President and CEO | Sep 02 | Withheld — tax / exercise cost · F | −54,276 | $25.70 | −$1.39M | 518,447 |
| Foster Julie | President, Front Line Care | Sep 02 | Withheld — tax / exercise cost · F | −2,098 | $25.70 | −$53.9K | 29,164 |
| Teaff James | President, CCS | Sep 01 | Withheld — tax / exercise cost · F | −750 | $25.48 | −$19.1K | 30,370 |
| Teaff James | President, CCS | Jun 02 | Withheld — tax / exercise cost · F | −321 | $18.68 | −$6K | 31,063 |
| Wallace Steven P. | President, Adv. Surgery | Jun 02 | Withheld — tax / exercise cost · F | −153 | $18.68 | −$2.86K | 70,128 |
| Zielinski Anita A | SVP, Interim CFO, CAO & Cntrlr | Jun 01 | Grant / award · A | +13,426 | — | — | 59,714 |
| Ampofo William A. Ii | Director | May 05 | Grant / award · A | +12,836 | — | — | 30,375 |
| Craig Jeffrey A | Director | May 05 | Grant / award · A | +12,836 | — | — | 23,662 |
| Mcdonnell Michael R | Director | May 05 | Grant / award · A | +12,836 | — | — | 14,647 |
| Shafer David Brent | Director | May 05 | Grant / award · A | +12,836 | — | — | 72,804 |
| Morrison Patricia | Director | May 05 | Grant / award · A | +12,836 | — | — | 42,386 |
| Schlichting Nancy M | Director | May 05 | Grant / award · A | +12,836 | — | — | 34,994 |
| Wendell Amy McBride | Director | May 05 | Grant / award · A | +12,836 | — | — | 44,235 |
| Wilkes David S. | Director | May 05 | Grant / award · A | +12,836 | — | — | 37,076 |
| Grade Joel T. | EVP and CFO | Mar 06 | Withheld — tax / exercise cost · F | −8,153 | $17.69 | −$144K | 271,674 |
| Rasul Reaz | EVP,Group Pres,Healthcare | Mar 06 | Withheld — tax / exercise cost · F | −12,674 | $17.69 | −$224K | 125,557 |
| Rosenbloom David S. | EVP and General Counsel | Mar 06 | Withheld — tax / exercise cost · F | −6,620 | $17.69 | −$117K | 138,216 |
| Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Mar 06 | Withheld — tax / exercise cost · F | −2,848 | $17.69 | −$50.4K | 75,045 |
| Zielinski Anita A | SVP, CAO and Controller | Mar 06 | Withheld — tax / exercise cost · F | −1,932 | $17.69 | −$34.2K | 46,281 |
| Rosenbloom David S. | EVP and General Counsel | Mar 02 | Withheld — tax / exercise cost · F | −1,336 | $19.69 | −$26.3K | 144,837 |
Loading...
